The mRNA expression of METTL14 showed an increasing trend in IDH -wildtype GBM in the Microarray cohort, but there was no significant difference among different glioma subtypes in the RNA-seq cohort (Additional file 1 : Fig.
← all excerpts
YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m<sup>6</sup>A modification to activate NF-κB and promote the malignant progression of glioma.
1
—
—